Companies: 10,795·Total market cap: $144.5T
Quanterix Corporation

Quanterix Corporation

QTRXNASDAQHealthcare● Active
$3.13
$-0.17(-5.15%)
Market Cap$147441721
P/E Ratio
52W High$8.77
52W Low$2.395

Quanterix Corporation (QTRX) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

qtrx · pe ratio · data through Dec 31, 2025

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Quanterix Corporation (QTRX) measures how much investors pay for each dollar of the company's trailing earnings. QTRX's current PE ratio of N/A is calculated by dividing its stock price of $3.13 by its TTM earnings per share of -$2.22.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31

Forward P/E
N/A
FY2027 est. EPS $-1.33
Based on 1 analyst
EPS (TTM)
-$2.22
TTM · diluted EPS
PEG Ratio
0.02
Below 1.0 · Growth adjusted
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Quanterix Corporation SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-08

PE Ratio History

2015 – 2025 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Medical - Devices · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Quanterix Corporation
Quanterix CorporationYou
QTRX
$147MN/A-$2.22
CVRx, Inc.
CVRx, Inc.
CVRX
$143MN/A-$2.04
Immuneering Corporation
Immuneering Corporation
IMRX
$143MN/A-$1.27
Inogen, Inc.
Inogen, Inc.
INGN
$164MN/A-$0.84
908 Devices Inc.
908 Devices Inc.
MASS
$306MN/A-$1.01
Nano-X Imaging Ltd.
Nano-X Imaging Ltd.
NNOX
$127MN/A-$1.16
Outset Medical, Inc.
Outset Medical, Inc.
OM
$80MN/A-$5.37

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 10 of 11 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2025-12-31Latest
FY2025
$-2.51
2024-12-31
FY2024
$-1.00
2023-12-31
FY2023
$-0.75
2022-12-31
FY2022
$-2.69
2021-12-31
FY2021
$-1.54
2020-12-31
FY2020
$-1.07
2019-12-31
FY2019
$-1.63
2018-12-31
FY2018
$-1.41
2017-12-31
FY2017
$-1.24
2016-12-31
FY2016
$-1.43

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Quanterix Corporation (QTRX) measures how much investors pay for each dollar of the company's trailing earnings. QTRX's current PE ratio of N/A is calculated by dividing its stock price of $3.13 by its TTM earnings per share of -$2.22.

PE Ratio = Stock Price ÷ EPS (TTM)
= $3.13 ÷ -$2.22 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

QTRX pe ratio · 6 questions

QTRX's current PE ratio is N/A as of 2026-06-08, based on a stock price of $3.13 and TTM EPS of -$2.22. Data sourced from Financial Modeling Prep via QTRX's SEC 10-K and 10-Q filings.

QTRX PE ratioWhat is QTRX PE ratioCurrent PE ratio of QTRXQTRX PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Quanterix Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08